AN2 Therapeutics, Inc.
ANTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51,321 | -$64,732 | -$40,956 | -$21,543 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8,338 | $8,412 | $4,391 | $974 |
| Change in WC | -$2,995 | $5,834 | $3,718 | $32 |
| Other Non-Cash | -$3,279 | -$2,802 | -$615 | $53 |
| Operating Cash Flow | -$49,257 | -$53,288 | -$33,462 | -$20,484 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$46,751 | -$132,178 | -$93,836 | -$77,274 |
| Inv. Sales/Matur. | $101,340 | $88,900 | $72,065 | $27,250 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $54,589 | -$43,278 | -$21,771 | -$50,024 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $372 | $84,529 | $70,366 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $465 | -$11 | $78,535 |
| Financing Cash Flow | $372 | $84,994 | $70,355 | $78,535 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $5,704 | -$11,572 | $15,122 | $8,027 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15,647 | $27,219 | $12,097 | $4,070 |
| End Cash | $21,351 | $15,647 | $27,219 | $12,097 |
| Free Cash Flow | -$49,257 | -$53,288 | -$33,462 | -$20,484 |